S No Panel Genes Covered Sample type TAT
1 BRCA1, BRCA2 somatic mutation* BRCA1, BRCA2 2ug DNA or 2ml EDTA Blood 7 – 8weeks
2 BRCA1/BRCA2 Full Gene Sequencing BRCA1, BRCA2 2ml EDTA Blood or
2ug purified genomic
DNA or 1 filter card
12 days
3 BRCA deletion/duplication with MLPA BRCA1, BRCA2 1ml EDTA Blood or
2ug purified genomic
DNA or 1 filter card
4 Breast ovarian cancer panel* CDH1, PTEN, STK11, TP53 2ug DNA or 2ml EDTA Blood 7 – 8 weeks
5 Breast ovarian cancer panel ADVANCED* ATM, BARD1, BRIP1, CHEK2, MEN1, MLH1, MRE11A,
MSH2, MSH6, MUTYH, NBN, PALB2, PMS1, PMS2,
RAD50, RAD51C, RAD51D, XRCC2
2ug DNA or 2ml EDTA Blood 7 – 8 weeks
6 Cancer Hotspot Panel* Most frequent mutations in genes ABL1, AKT1,
ALK, APC, ATM, BRAF, CDH1, CDKN2A, CSF1R, CTNNB1,
EGFR, ERBB2, ERBB4, EZH2, FBXW7, FGFR1, FGFR2,
FGFR3, GNA11, GNAQ, GNAS, HNF1A, HRAS, IDH1, IDH2,
JAK2, JAK3, KDR, KIT, KRAS, MET, MLH1, MPL, NOTCH1,
NPM1, NRAS, PDGFRA, PIK3CA, PTEN,PTPN11, RB1, RET,
SMAD4, SMARCB1, SMO, SRC, STK11, TP53, VHL
2ug DNA or 2ml EDTA Blood 7 – 8 weeks
7 Breast cancer panel* BRCA1, BRCA2, TP53, PTEN, STK11, CDH1, PALB2,
CHEK2, ATM, NBN, BARD1, BRIP1, RAD51C
2ug DNA or 2ml EDTA Blood 7 – 8 weeks
8 Cancer Panel comprehensive* APC, ATM, BARD1, BLM, BMPR1A, BRCA1, BRCA2,
BRIP1, CDH1, CDK4, CDKN2A, CHEK2, EPCAM, FH,
FLCN, MLH1, MSH2, MSH6, MUTYH, NBN, NTHL1,
PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D,
SMAD4, STK11, TP53
2ug DNA or 2ml EDTA Blood 7 – 8 weeks
9 Lynch syndrome or Colon cancer
non-polyposis*
MSH2, MLH1, MSH6, PMS2, EPCAM 2ug DNA or 2ml EDTA Blood 7 – 8 weeks
10 Colon cancer with polyps panel* APC, BMPR1A, MUTYH, PTEN, SMAD4, STK11 2ug DNA or 2ml EDTA Blood 7 – 8 weeks
11 Hereditary cancers* ALK, APC, ATM, BAP1, BLM, BMPR1A, BRIP1, CDC73,
CDH1, CDK4, CDKN2A, CEBPA, CHEK2, CYLD, DDB2,
DICER1, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, EXT1,
EXT2, EZH2, FANCA, FANCC, FANCD2, FANCF, FANCG,
FH, FLCN, GATA2, GDNF, HNF1A, HRAS, KIT, MEN1,
MET, MITF, MLH1, MSH2, MSH6, MUTYH, NBN, NF1,
NF2, NSD1, PALB2, PAX5, PDGFRA, PHOX2B, PMS1,
PMS2, POT1, PRKAR1A, PTCH1, PTEN, RB1, RECQL4,
RET, RUNX1, SBDS, SDHA, SDHB, SDHC, SDHD, SMAD4,
SMARCB1, STK11, SUFU, TP53,TSC1, TSC2, VHL, WRN,
WT1, XPA, XPC
2ug DNA or 2ml EDTA Blood 7 – 8 weeks
12 Fanconi anemia* BRCA2, BRIP1, FANCA, FANCB, FANCC, FANCD2,
FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, PALB2,
SLX4, XRCC2
2ug DNA or 2ml EDTA Blood 7 – 8 weeks
13 Gastric cancer* BMPR1A, CDH1, EPCAM, MLH1, MSH2, MSH6, PMS1,
PMS2, SMAD4
2ug DNA or 2ml EDTA Blood 7 – 8 weeks
14 Myeloid Tumor Somatic Mutation* ABL1 (Ex4-Ex6), ASXL1 (Ex12), ATRX (Ex08-10,
Ex17- 31), BCOR(full gene), BCORL1 (full gene), BRAF
(Ex15),CALR (Ex09), CBL(Ex08-E09), CBLB (Ex09, Ex10),
CBLC (Ex09, Ex10), CDKN2A (fullgene), CEBPA (full gene),
CSF3R (Ex14-Ex17), CUX1 (full gene),DNMT3A (full
gene), ETV6/TEL (full gene), EZH2 (full gene),FBXW7
(Ex09-Ex11), FLT3 (Ex14-Ex15, Ex20), GATA1
(Ex02),GATA2 (Ex02-Ex06), GNAS (Ex08-Ex09), HRAS
(Ex02-Ex03), IDH1 (Ex04), IDH2 (Ex04), IKZF1 (full
gene), JAK2 (Ex12, Ex14), JAK3(Ex13), KDM6A (full gene),
KIT (Ex2,Ex8-Ex11, Ex13, Ex17), KRAS(E02-E03),
MLL (Ex05-Ex08), MPL (Ex10), MYD88 (Ex03,
Ex04,Ex05), NOTCH1 (Ex26-Ex27, Ex34), NPM1 (Ex12),
NRAS (Ex02-Ex03), PDGFRA (Ex12, Ex14, Ex18), PHF6
(full gene), PTEN (Ex05,Ex07), PTPN11 (Ex3, Ex13),
RAD21 (full gene), RUNX1 (full gene),SETBP1 (Ex04
(partial)), SF3B1 (Ex13-Ex16), SMC1A (Ex2, Ex11,Ex16,
Ex17), SMC3 (Ex10, Ex13, Ex19, Ex23, Ex25, Ex28),
SRSF2,(Ex01), STAG2 (full gene), TET2 (Ex3-Ex11), TP53
(Ex2-Ex11),U2AF1 (Ex02, Ex06), WT1 (Ex07, Ex09),
ZRSR2 (full gene)
2ug DNA or 2ml EDTA Blood 7 – 8 weeks
15 Ovarian cancer* BARD1, BRCA1, BRCA2, BRIP1, EPCAM, MLH1,
MRE11A, MSH2, MSH6, NBN, PMS1, PMS2, RAD50,
RAD51C, RAD51D, STK11, TP53
2ug DNA or 2ml EDTA Blood 7 – 8 weeks
16 Pancreatic cancer panel* APC, ATM, BMPR1A, CDKN2A, EPCAM, MLH1, MSH2,
MSH6, PALB2, PMS1, PMS2, PRSS1, SMAD4, STK11
2ug DNA or 2ml EDTA Blood 7 – 8 weeks
17 PGL / PCC / GIST* 2ug DNA or 2ml EDTA Blood 7 – 8 weeks
18 Pheochromocytoma* 2ug DNA or 2ml EDTA Blood 7 – 8 weeks
19 Prostate cancer* 2ug DNA or 2ml EDTA Blood 7 – 8 weeks
20 Renal cancer* 2ug DNA or 2ml EDTA Blood 7 – 8 weeks
21 Skin cancer* 2ug DNA or 2ml EDTA Blood 7 – 8 weeks
22 Solid Tumor Somatic Mutations* 2ug DNA or 2ml EDTA Blood 7 – 8 weeks
23 Thyroid cancer* 2ug DNA or 2ml EDTA Blood 7 – 8 weeks
24 Tuberous sclerosis* 2ug DNA or 2ml EDTA Blood 7 – 8 weeks
25 Uterine cancer* 2ug DNA or 2ml EDTA Blood 7 – 8 weeks
26 MMG Panel for Hereditary Cancer Syndromes* 2ug DNA or 2ml EDTA Blood 7 – 8 weeks
27 Lung Cancer and Nicotine Dependence Test
28 TSC1 deletion/duplication analysis – MLPA
29 TSC2 deletion/duplication analysis – MLPA
30 Karyotyping Analysis (single)
31 Karyotyping Analysis (Couple)
32 Chromosomal CGH microarray – 750K Array
33 Clinical Exome Sequencing
34 Whole Exome Sequencing*
35 Whole Exome Sequencing (WES) Trio
36 Whole Genome Sequencing Entire Genome 2ml EDTA Blood or 3 Buccal swabs
or 1ug purified genomic DNA
7 – 8 weeks
37 Targeted single exon mutation analysis Single exon of the indicated gene EDTA Blood or DNA 3 – 4 weeks

*This test is available at a 25-day TAT at an additional cost